화학공학소재연구정보센터
검색결과 : 8건
No. Article
1 Natural and synthetic drugs used for the treatment of the dementia
Dembitsky VM, Dzhemileva L, Gloriozova T, D'yakonov V
Biochemical and Biophysical Research Communications, 524(3), 772, 2020
2 Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA system
Muneoka S, Nakamura R, Hoshino M, Utsugisawa K, Makino T
Journal of Bioscience and Bioengineering, 126(4), 522, 2018
3 Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis
Ayyar BV, Atassi MZ
Applied Microbiology and Biotechnology, 101(22), 8165, 2017
4 Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
Pohanka M, Dobes P
International Journal of Molecular Sciences, 14(5), 9873, 2013
5 The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis
Moser B, Bekos C, Zimprich F, Nickl S, Klepetko W, Ankersmit J
Biochemical and Biophysical Research Communications, 420(1), 96, 2012
6 Novel immunotoxin: A fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis
Hossann M, Li ZY, Shi YW, Kreilinger U, Buttner J, Vogel PD, Yuan JM, Wise JG, Trommer WE
Protein Expression and Purification, 46(1), 73, 2006
7 Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection
Hwang B, Lee SW
Biochemical and Biophysical Research Communications, 290(2), 656, 2002
8 Maintenance of Acetylcholine-Receptor Number by Neuregulins at the Neuromuscular-Junction in-Vivo
Sandrock AW, Dryer SE, Rosen KM, Gozani SN, Kramer R, Theill LE, Fischbach GD
Science, 276(5312), 599, 1997